Minerva Net Debt vs Cash Analysis

NERV Stock  USD 2.82  0.03  1.05%   
Minerva Neurosciences financial indicator trend analysis is infinitely more than just investigating Minerva Neurosciences recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Minerva Neurosciences is a good investment. Please check the relationship between Minerva Neurosciences Net Debt and its Cash accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.

Net Debt vs Cash

Net Debt vs Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Minerva Neurosciences Net Debt account and Cash. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Minerva Neurosciences' Net Debt and Cash is -0.47. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Cash in the same time period over historical financial statements of Minerva Neurosciences, assuming nothing else is changed. The correlation between historical values of Minerva Neurosciences' Net Debt and Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Minerva Neurosciences are associated (or correlated) with its Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cash has no effect on the direction of Net Debt i.e., Minerva Neurosciences' Net Debt and Cash go up and down completely randomly.

Correlation Coefficient

-0.47
Relationship DirectionNegative 
Relationship StrengthVery Weak

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Cash

Cash refers to the most liquid asset of Minerva Neurosciences, which is listed under current asset account on Minerva Neurosciences balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Minerva Neurosciences customers. The amounts must be unrestricted with restricted cash listed in a different Minerva Neurosciences account. The total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts.
Most indicators from Minerva Neurosciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Minerva Neurosciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Minerva Neurosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.At this time, Minerva Neurosciences' Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to climb to 0.00 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (3.68) in 2024.
 2023 2024 (projected)
Extraordinary Items8.5M7.5M
Reconciled Depreciation29.6K57.8K

Minerva Neurosciences fundamental ratios Correlations

-0.470.810.76-0.43-0.340.650.960.650.46-0.010.620.480.960.70.040.180.720.630.630.010.750.690.360.170.36
-0.47-0.48-0.40.130.110.06-0.5-0.27-0.24-0.19-0.28-0.24-0.5-0.440.25-0.7-0.24-0.45-0.280.16-0.28-0.2-0.18-0.710.1
0.81-0.480.66-0.45-0.260.630.730.550.340.090.490.310.730.65-0.050.370.670.650.590.040.710.650.160.390.01
0.76-0.40.66-0.720.260.310.670.2-0.040.010.14-0.10.660.7-0.580.140.330.190.88-0.50.880.24-0.230.150.33
-0.430.13-0.45-0.72-0.22-0.47-0.41-0.130.05-0.35-0.090.15-0.41-0.770.47-0.23-0.18-0.24-0.490.62-0.56-0.070.24-0.13-0.32
-0.340.11-0.260.26-0.22-0.57-0.41-0.87-0.91-0.4-0.91-0.82-0.42-0.28-0.78-0.3-0.73-0.70.41-0.550.14-0.79-0.8-0.27-0.05
0.650.060.630.31-0.47-0.570.680.730.630.150.70.590.690.540.420.010.70.640.10.160.330.690.51-0.050.26
0.96-0.50.730.67-0.41-0.410.680.680.580.010.660.571.00.670.130.150.660.670.470.050.590.640.480.130.35
0.65-0.270.550.2-0.13-0.870.730.680.920.420.990.810.690.610.50.370.910.79-0.050.260.270.910.740.330.18
0.46-0.240.34-0.040.05-0.910.630.580.920.40.940.830.590.420.60.290.70.76-0.310.41-0.050.730.80.260.17
-0.01-0.190.090.01-0.35-0.40.150.010.420.40.450.040.020.63-0.010.650.290.33-0.27-0.2-0.090.250.00.55-0.13
0.62-0.280.490.14-0.09-0.910.70.660.990.940.450.820.670.590.540.390.880.79-0.10.290.20.890.750.350.19
0.48-0.240.31-0.10.15-0.820.590.570.810.830.040.820.580.230.730.160.710.74-0.270.40.00.730.990.110.14
0.96-0.50.730.66-0.41-0.420.691.00.690.590.020.670.580.670.150.150.670.670.470.050.580.650.490.130.35
0.7-0.440.650.7-0.77-0.280.540.670.610.420.630.590.230.67-0.220.570.630.630.43-0.360.620.540.120.480.29
0.040.25-0.05-0.580.47-0.780.420.130.50.6-0.010.540.730.15-0.22-0.210.40.35-0.590.7-0.430.50.78-0.25-0.18
0.18-0.70.370.14-0.23-0.30.010.150.370.290.650.390.160.150.57-0.210.350.560.03-0.190.160.30.10.98-0.04
0.72-0.240.670.33-0.18-0.730.70.660.910.70.290.880.710.670.630.40.350.740.230.20.540.990.60.330.16
0.63-0.450.650.19-0.24-0.70.640.670.790.760.330.790.740.670.630.350.560.740.050.290.270.750.670.510.27
0.63-0.280.590.88-0.490.410.10.47-0.05-0.31-0.27-0.1-0.270.470.43-0.590.030.230.05-0.340.930.17-0.380.080.33
0.010.160.04-0.50.62-0.550.160.050.260.41-0.20.290.40.05-0.360.7-0.190.20.29-0.34-0.340.360.44-0.13-0.11
0.75-0.280.710.88-0.560.140.330.590.27-0.05-0.090.20.00.580.62-0.430.160.540.270.93-0.340.46-0.130.190.36
0.69-0.20.650.24-0.07-0.790.690.640.910.730.250.890.730.650.540.50.30.990.750.170.360.460.640.290.14
0.36-0.180.16-0.230.24-0.80.510.480.740.80.00.750.990.490.120.780.10.60.67-0.380.44-0.130.640.050.14
0.17-0.710.390.15-0.13-0.27-0.050.130.330.260.550.350.110.130.48-0.250.980.330.510.08-0.130.190.290.05-0.03
0.360.10.010.33-0.32-0.050.260.350.180.17-0.130.190.140.350.29-0.18-0.040.160.270.33-0.110.360.140.14-0.03
Click cells to compare fundamentals

Minerva Neurosciences Account Relationship Matchups

Minerva Neurosciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets77.5M57.6M77.1M55.1M56.9M88.0M
Other Current Liab(41.2B)2.1M965.7K407.9K1.5M1.6M
Total Current Liabilities6.6M3.2M2.8M1.4M3.3M4.4M
Total Stockholder Equity27.8M52.7M8.0M(20.0M)(28.5M)(27.0M)
Net Debt(21.1M)(25.2M)(60.8M)37.6M41.0M43.1M
Retained Earnings(286.7M)(284.8M)(334.7M)(366.8M)(396.8M)(377.0M)
Cash21.4M25.4M60.8M36.1M41.0M34.7M
Cash And Short Term Investments45.9M25.4M60.8M36.1M41.0M51.4M
Common Stock Total Equity3.9K3.9K3.9K4.3K4.9K3.0K
Common Stock Shares Outstanding4.9M5.1M5.3M5.3M6.5M4.6M
Liabilities And Stockholders Equity77.5M57.6M77.1M55.1M56.9M88.0M
Other Current Assets1.3B2.1B1.4B4.0M989.9K940.4K
Other Stockholder Equity314.5M337.5M342.7M346.8M368.4M264.5M
Total Liab49.7M5.0M69.1M75.1M85.4M42.7M
Total Current Assets47.1M27.4M62.2M40.2M42.0M52.9M
Common Stock3.9K4K4.3K534.0699.0664.05
Property Plant And Equipment Net278K101.8K51.1K16.3K10.9K10.3K
Accounts Payable2.3M995.6K1.9M969.7K1.8M1.5M
Non Current Assets Total30.4M30.2M14.9M14.9M14.9M27.9M
Non Current Liabilities Total43.1M1.8M66.3M73.7M82.0M41.8M
Property Plant And Equipment Gross278.0K101.8K0.016.3K18.8K17.8K
Short Term Debt4.0M41.2B173K111.2K127.9K121.5K
Property Plant Equipment33.5K16.0K101.8K16.3K18.8K36.8K
Other Liab43.0M1.8M66.3M73.7M84.8M89.0M
Net Tangible Assets(2.3M)22.6M(6.9M)(34.9M)(31.4M)(29.9M)
Retained Earnings Total Equity(164.4M)(214.6M)(286.7M)(284.8M)(256.3M)(269.1M)
Capital Surpluse296.0M304.8M314.5M337.5M388.1M278.9M
Non Current Liabilities Other41.2M41.3M66.3M73.7M82.0M41.9M
Net Invested Capital27.8M52.7M8.0M(20.0M)(28.5M)(27.0M)
Net Working Capital40.5M24.3M59.4M38.8M38.7M46.9M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Minerva Stock Analysis

When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.